These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 6815486)

  • 1. [Risk factors and primary prevention in mild hypertension].
    Borgers D
    MMW Munch Med Wochenschr; 1982 Jul; 124(28):655-9. PubMed ID: 6815486
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary and secondary prevention of arteriosclerosis. Risk stratification of hypertension].
    Gysan DB
    Z Kardiol; 2002 Oct; 91(10):777-85. PubMed ID: 12395218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of prevention and control of primary hypertension].
    Li L
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Jun; 21(3):165-6. PubMed ID: 15460007
    [No Abstract]   [Full Text] [Related]  

  • 4. Hypertension in Africa: an overview of prevalence rates and causal risk factors.
    Kaufman J; Barkey N
    Ethn Dis; 1993; 3 Suppl():S83-101. PubMed ID: 8087029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Managing hypertension: measurement and prevention.
    Hurst R
    Nurs Times; 2002 Sep 17-23; 98(38):38-40. PubMed ID: 12355920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology of early primary hypertension and implications for prevention: the Bogalusa Heart Study.
    Berenson GS; Wattigney WA; Bao W; Nicklas TA; Jiang X; Rush JA
    J Hum Hypertens; 1994 May; 8(5):303-11. PubMed ID: 8064774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Religious, economic and pharmacodynamic factors that hinder the prevention of essential hypertension.
    Tekol Y
    Med Hypotheses; 2007; 69(2):471-2. PubMed ID: 17280800
    [No Abstract]   [Full Text] [Related]  

  • 8. The altered homeostatic theory: A hypothesis proposed to be useful in understanding and preventing ischemic heart disease, hypertension, and diabetes--including reducing the risk of age and atherosclerosis.
    Hellstrom HR
    Med Hypotheses; 2007; 68(2):415-33. PubMed ID: 16828234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Environmental influences as risk factors - their recognition as a first step in high blood pressure prevention].
    Bock KD
    Verh Dtsch Ges Inn Med; 1980; 86():303-10. PubMed ID: 7223023
    [No Abstract]   [Full Text] [Related]  

  • 10. Using NOC outcome of risk control in prevention, early detection, and control of hypertension.
    Peters RM
    Outcomes Manag Nurs Pract; 2000; 4(1):39-45. PubMed ID: 11029942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ashkelon hypertension prevention and control program.
    Viskoper RJ; Klier E; Oren S; Laszt A; Tal B; Klier M
    Bibl Cardiol; 1987; (42):45-7. PubMed ID: 3632617
    [No Abstract]   [Full Text] [Related]  

  • 12. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Control of blood pressure: a key factor in prevention].
    Suter PM; Häsler E; Vetter W
    Praxis (Bern 1994); 1998 Jan; 87(5):145-9, 152-6. PubMed ID: 9522632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Arterial hypertension].
    Beaufils M
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):899-900. PubMed ID: 10989726
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of hypertension.
    Dustan HP
    Heart Dis Stroke; 1992; 1(6):337-9. PubMed ID: 1344128
    [No Abstract]   [Full Text] [Related]  

  • 16. Cardiovascular prevention (VI). Use of drugs in the primary prevention of arterial hypertension and dyslipidemia.
    González-Juanatey JR; Mazón Ramos P
    Rev Esp Cardiol; 2008 Aug; 61(8):861-79. PubMed ID: 18684369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salt and hypertension.
    Tobian L
    J Med Assoc Ga; 1980 Oct; 69(10):827-34. PubMed ID: 7430844
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary prevention of hypertension: rationale, approaches, realities and perspectives.
    Whelton PK
    J Hum Hypertens; 1996 Feb; 10 Suppl 1():S47-50. PubMed ID: 8965288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The nature and causes of the development of hypertension and the importance of the diagnosis of this nosological form for the prophylaxis and differentiated treatment of patients].
    Gogin EE
    Ter Arkh; 1993; 65(12):6-11. PubMed ID: 8146775
    [No Abstract]   [Full Text] [Related]  

  • 20. Primary prevention with beta-blockade in patients with hypertension: review of results and clinical implications.
    Wikstrand J
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S64-75. PubMed ID: 11527139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.